Results 291 to 300 of about 716,057 (309)
Some of the next articles are maybe not open access.
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Ciara C O’sullivan+2 more
exaly
Challenges and Opportunities in Cancer Drug Resistance
Chemical Reviews, 2021Richard A Ward+2 more
exaly
An update on the immune landscape in lung and head and neck cancers
Ca-A Cancer Journal for Clinicians, 2020Jennifer W Carlisle+2 more
exaly
Fecal microbiota transplants may aid melanoma immunotherapy resistance
Ca-A Cancer Journal for Clinicians, 2021exaly
Photodynamic therapy of cancer: An update
Ca-A Cancer Journal for Clinicians, 2011Patrizia Agostinis+2 more
exaly
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap, Johann S De Bono
exaly
The great escape: tumour cell plasticity in resistance to targeted therapy
Nature Reviews Drug Discovery, 2020Frederic J De Sauvage
exaly
Targeting multidrug resistance in cancer
Nature Reviews Drug Discovery, 2006Gergely Szakács, Michael M Gottesman
exaly
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Advanced Pharmaceutical Bulletin, 2017Behzad Mansoori+2 more
exaly